Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C28H31NO5.CH4O3S |
| Molecular Weight | 557.655 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CS(O)(=O)=O.CC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2OC(=O)C3=CC=C(C)C=C3)C(O)CNC(C)(C)C
InChI
InChIKey=HODFCFXCOMKRCG-UHFFFAOYSA-N
InChI=1S/C28H31NO5.CH4O3S/c1-18-6-10-20(11-7-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21;1-5(2,3)4/h6-16,23,29-30H,17H2,1-5H3;1H3,(H,2,3,4)
| Molecular Formula | CH4O3S |
| Molecular Weight | 96.106 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C28H31NO5 |
| Molecular Weight | 461.5494 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Bitolterol is a beta 2-adrenergic agonist. Since it in itself is biologically inactive, bitolterol is considered a pro-drug. When administered it is activated within the lung by esterase hydrolysis to the active compound colterol catecholamine N-t-butyl-arterenol. Bitolterol was marked under the name tornalate and was indicated to prevent and treat of reversible bronchospasm associated with asthma or chronic obstructive pulmonary diseases. But that drug was withdrawn from the market by Elan Pharmaceuticals in 2001.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL210 Sources: https://www.ncbi.nlm.nih.gov/pubmed/3278878 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | TORNALATE Approved UseUnknown Launch Date1984 |
|||
| Primary | TORNALATE Approved UseUnknown Launch Date1984 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Accuracy of Veterans Affairs databases for diagnoses of chronic diseases. | 2009-10 |
|
| Efficacy and safety of inhaled bitolterol mesylate via metered-dose inhaler in children with asthma. | 1996-01 |
|
| Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm. | 1995-04-08 |
|
| Multicenter dose-ranging study of bitolterol mesylate solution for nebulization in children with asthma. | 1994-03 |
|
| Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease. | 1988-01 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/ppa/bitolterol-mesylate.html
Acute Bronchospasm: adults and children older than 12 yr of age: oral inhalation 2 inhalations at interval of 1 to 3 min, followed by third inhalation if necessary.
Prevention of Bronchospasm: adults and children older than 12 yr of age: oral inhalation 2 inhalations every 8 h, not to exceed 3 inhalations every 6 h or 2 inhalations every 4 h.
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:56:07 GMT 2025
by
admin
on
Mon Mar 31 17:56:07 GMT 2025
|
| Record UNII |
4E53T3611U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C319
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
||
|
NCI_THESAURUS |
C48149
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
35329
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
47187
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | RxNorm | ||
|
C65268
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
SUB00836MIG
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
CHEMBL1201295
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
250-177-5
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
30392-41-7
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
DBSALT002788
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
DTXSID80952735
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
m2578
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | Merck Index | ||
|
100000085139
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
4E53T3611U
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY | |||
|
3134
Created by
admin on Mon Mar 31 17:56:07 GMT 2025 , Edited by admin on Mon Mar 31 17:56:07 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |